ALZ-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALZ-101, covering 2025-01-31 to 2025-01-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease [Phase 1]